NCT05994534View on ClinicalTrials.gov

PK and PD Study of NPI-001 and Cysteamine Bitartrate

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 29, 2023

Primary Completion Date

April 21, 2025

Study Completion Date

June 21, 2025

Conditions
Cystinosis
Interventions
DRUG

Cysteamine Bitartrate

Single dose, tablets at current therapeutic dose

DRUG

N-Acetylcysteine Amide

Single dose, oral solution

Trial Locations (1)

2145

RECRUITING

Children's Hospital at Westmead, Westmead

Sponsors
All Listed Sponsors
lead

Nacuity Pharmaceuticals, Inc.

INDUSTRY

NCT05994534 - PK and PD Study of NPI-001 and Cysteamine Bitartrate | Biotech Hunter | Biotech Hunter